VVVitor Bonetti Valente

Vitor Bonetti Valente

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vitor Bonetti Valente has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Specific Depressive Symptoms and Primary Tumor Location as Potential Predictors of Smoking Maintenance After Head and Neck Cancer Treatment

    by Ana Daniela Spínola‐Silva, Jéssica Soares Bugiga, Bruna Amélia Moreira Sarafim‐Costa, Gabrielle Dias Duarte, Ana Lívia Santos‐Sousa, Rafael Akira Tzanno Murayama, Aline Satie Takamiya, Éder Ricardo Biasoli, Vitor Bonetti Valente, Glauco Issamu Miyahara, et al.

    Background: Despite the known benefits of smoking cessation for head and neck cancer (HNC) patients, a significant proportion continue to use tobacco after treatment. Although the causes of this phenomenon are multifactorial, the underlying psychological mechanisms are still poorly understood. Aim: Investigate the influence of sociodemographic, clinicopathological, and psychological factors on smoking cessation after treatment of HNC. Methods: This study included 71 smoking HNC patients who had completed cancer treatment for at least 12 months. Clinicopathological characteristics and anxiety and depression symptoms extracted the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) were evaluated in the pre‐treatment period. Data on smoking history was assessed through a semi‐structured interview. Results: A proportion of patients with HNC patients (39.4%) continued to smoke immediately after completing cancer treatment, with this proportion rising to 43.7% after 12 months of treatment. Logistic regression analyses showed that the occurrence of the primary tumor in the oral cavity ( β = 6.891, P = 0.008) and the psychological symptom of sadness measured by the BDI ( β = 5.279, P = 0.023) were predictive of smoking maintenance 12 months after the end of cancer treatment. Feeling like a failure before cancer treatment was the only predictor variable for smoking maintenance immediately after and 12 months after the end of treatment ( β = 13.455, p < 0.001; β = 4.537, P = 0.043; respectively). Conclusion: This study presents exploratory insights that identifies pre‐treatment specific depressive symptoms and primary tumor location as promising predictive factors for continued tobacco use in patients treated for head and neck cancer.

  • Open Access

    Difficulties and Feelings Experienced by Undergraduate Dental Students When Caring for Patients

    by Bruna B. Rodrigues, Ana L. Santos‐Sousa, Tamara F. Castro, Vitor B. Valente, Glauco I. Miyahara, Daniel G. Bernabé

    Purpose: Dealing with the patient's illness process is part of the academic trajectory of healthcare students. The relationship between patients and their healthcare professionals can be complex and challenging, especially for undergraduate dental students. The purpose of this study was to evaluate the perceptions, feelings, and difficulties of dental students triggered when caring for patients during their undergraduate course. Methods: Eighty‐six undergraduate dental students responded to a semi‐structured questionnaire about their experiences with patient care in the oral medicine clinic. Results: Forty‐two students (48.8%) felt uncomfortable with the patients’ anamnesis questions. Among these, the inquiries about sexually transmitted infections (STIs) were the most discomforting topic to address with the patient (65%), followed by drug abuse (35%) and sexual behavior (15%). According to the students, the most difficult topic to discuss with the patient was a negative diagnosis (40%), followed by STIs and sexual behavior (25.3%), and physical and sexual violence (20%). During patient care, the main challenging issue was dealing with uncooperative patients, reported by 29 students (36.7%). About the challenges faced during patient interviews, the majority of the students reported feeling bad when the patient shared a negative life story (90.7%) or when they described a traumatic life event (83.7%). A portion of the students (26.7%) reported that this discomfort in hearing a patient's negative life story can negatively impact the care they provide to the patient. Conclusion: Dental students experience evident difficulties in clinical practice with patients in the oral medicine clinic, especially in relation to some themes addressed during the anamnesis. Knowledge of these difficulties is essential to develop new learning and teaching strategies and improve the students’ professional training during their dental undergraduate course.

  • Talquetamab‐Induced Dysgeusia Successfully Treated With Photobiomodulation Therapy

    by Giseli Mitsuy Kayahara, Raissa Baisso Espinhosa, Steffani Nascimento da Silva, Mariana Aparecida Sanches Pereira, Daniel Galera Bernabé, Glauco Issamu Miyahara, Mariana Stuchi Urazaki, Gabriel Macedo Cortopassi, Vitor Bonetti Valente

    Multiple myeloma is a malignancy characterized by clonal proliferation of plasma cells in the bone marrow. The treatment of patients with relapsed or refractory multiple myeloma remains a challenge. Talquetamab is a recently approved drug, a first‐in‐class GPRC5D‐targeting T‐cell redirecting bispecific antibody, for treatment of patients with triple‐class exposed relapsed/refractory multiple myeloma. Patients who underwent drug therapy have experienced oral side effects such as xerostomia and dysgeusia. This report describes the case of a 61‐year old man with triple‐class exposed refractory multiple myeloma who developed talquetamab‐related dysgeusia that was successfully treated with photobiomodulation (PBM). The patient began to complain of loss of taste three days after the administration of talquetamab. PBM was performed every 48 h with 25 J/cm 2 per treatment field using the Therapy EC device (DMC; model number: #75153; red: 660 nm ±10 nm; infrared: 808 nm ±10 nm; fixed power of 100 mW ±20%; beam area of 0.04 cm 2 , and irradiance of 2.5 W/cm 2 ) during the talquetamab escalation phase. The application of laser was performed in 78 points distributed throughout the oral cavity. After 7 days/third session of PBM, the patient displayed a significant improvement in sensitivity to tastes, mainly salty and bitter. After 7 weeks of follow‐up, there was a slight reduction in sensibility to salty and no change in other tastes. The current clinical report demonstrated the potential effectiveness of a PBM protocol developed for the treatment of talquetamab‐related dysgeusia. The management of this oral side effect using PBM could prevent treatment interruption and improve the patients' quality of life.


  • Associations of Pain, Anxiety, and Depressive Symptoms With Sleep Outcomes in Patients With Head and Neck Squamous Cell Carcinoma: A Cross‐Sectional Observational Study

    by Giseli Mitsuy Kayahara, Bruna Amélia Moreira Sarafim‐Costa, Marcus Vinícius Branco de Oliveira, Antônio Mendes Fontanelli, Yi Ye, Vitor Bonetti Valente, Eder Ricardo Biasoli, Glauco Issamu Miyahara, Daniel Galera Bernabé

    Background: This exploratory cross‐sectional observational study sought to characterize sleep quality and evaluate its association with sociodemographic, clinicopathological, behavioral, and psychological variables in patients with head and neck squamous cell carcinoma (HNSCC).Patients and Methods: Sleep problems from 132 HNC patients were assessed before starting oncological treatment through the questionnaires Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), and STOP‐Bang. Anxiety and depression symptoms were evaluated using the Hospital Anxiety and Depression Scale. Univariate analysis and multivariate logistic regression were performed to evaluate factors associated with sleep problems in HNSCC patients.Results: About 50% of the HNSCC patients reported poor overall sleep quality on the PSQI. Insomnia, excessive daytime sleepiness, and high risk of apnea were observed in 19%, 15%, and 54% of HNSCC patients, respectively. Our results showed that pain was associated with overall poor PSQI sleep quality and lower PSQI sleep efficiency, while the presence of regional metastasis was linked to overall PSQI good sleep. No other clinicopathological or behavioral (i.e., alcohol and tobacco use) variables were related to sleep outcomes. Higher occurrence of anxiety symptoms was related to poor overall PSQI sleep quality, decreased PSQI sleep efficiency, PSQI daytime dysfunction, and ISI insomnia. Moreover, higher occurrence of depression symptoms was associated with lower PSQI sleep latency and PSQI duration, and the occurrence of ESS excessive daytime sleepiness.Conclusion: Pain, anxiety, and depressive symptoms were associated with poor sleep quality and sleep problems in HNSCC patients before starting treatment. No sociodemographic or behavioral (i.e., alcohol and tobacco use) variables were related to sleep outcomes. Likewise, tumor location, T classification, and clinical staging were not linked to sleep quality and disorders in HNSCC patients.


  • Diffuse Large B-Cell Lymphoma (Not Otherwise Specified)

    by Vitor Bonetti Valente, Javier Rendon Henao, Felipe Paiva Fonseca

  • A rare development of classical Hodgkin lymphoma in the head and neck region

    by Mariana A.S. Pereira, Giulia R. Santos, Juan M.A. Legarrea, Giseli Mitsuy Kayahara, Felipe P. Fonseca, José Cândido C. Xavier-Junior, Glauco I. Miyahara, Daniel G. Bernabé, Mariana S. Urazaki, Gabriel M. Cortopassi, et al.


  • Primary manifestation of HIV-related Burkitt lymphoma in the oral and maxillofacial regions

    by Nilton José da Silva Filho, Diovana de Melo Cardoso, Giseli Mitsuy Kayahara, José Cândido Caldeira Xavier-Júnior, Gabriel Macedo Cortopassi, Felipe Paiva Fonseca, Glauco Issamu Miyahara, Daniel Galera Bernabé, Vitor Bonetti Valente


  • Ulcerated lesion in the hard palate of a child

    by Diovana de Melo Cardoso, Mariana de Oliveira Daltoé, Léa Assed Bezerra da Silva, Glauco Issamu Miyahara, André Caroli Rocha, Daniel Galera Bernabé, Vitor Bonetti Valente